ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,381 | +371.1% | 3,590 | +638.7% | 0.00% | – |
Q2 2023 | $2,416 | -11.7% | 486 | -12.3% | 0.00% | – |
Q1 2023 | $2,737 | +1111.1% | 554 | +1438.9% | 0.00% | – |
Q4 2022 | $226 | -97.5% | 36 | -95.6% | 0.00% | -100.0% |
Q3 2022 | $9,000 | 0.0% | 826 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $9,000 | -30.8% | 826 | -41.5% | 0.00% | -50.0% |
Q1 2022 | $13,000 | +160.0% | 1,413 | +294.7% | 0.00% | +100.0% |
Q4 2021 | $5,000 | +150.0% | 358 | +316.3% | 0.00% | – |
Q3 2021 | $2,000 | – | 86 | +975.0% | 0.00% | – |
Q2 2021 | $0 | – | 8 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |